1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active Pharmaceutical Ingredient
1.4.3 Biologics
1.4.4 Dry Powders
1.5 Market by Application
1.5.1 Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Companies
1.5.3 Contract Manufacturing Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Continuous Manufacturing Market Perspective (2015-2026)
2.2 Global Pharmaceutical Continuous Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Continuous Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Continuous Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutical Continuous Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical Continuous Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Continuous Manufacturing Players by Market Size
3.1.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical Continuous Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio
3.2.1 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Continuous Manufacturing Revenue in 2019
3.3 Pharmaceutical Continuous Manufacturing Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
3.5 Date of Enter into Pharmaceutical Continuous Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
6.2 Pharmaceutical Continuous Manufacturing Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
7.2 Pharmaceutical Continuous Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
8.2 Pharmaceutical Continuous Manufacturing Key Players in China (2019-2020)
8.3 China Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
8.4 China Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
9.2 Pharmaceutical Continuous Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
10.2 Pharmaceutical Continuous Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
11.2 Pharmaceutical Continuous Manufacturing Key Players in India (2019-2020)
11.3 India Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
11.4 India Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
12.2 Pharmaceutical Continuous Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens
13.1.1 Siemens Company Details
13.1.2 Siemens Business Overview
13.1.3 Siemens Pharmaceutical Continuous Manufacturing Introduction
13.1.4 Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020))
13.1.5 Siemens Recent Development
13.2 Corning Life Sciences
13.2.1 Corning Life Sciences Company Details
13.2.2 Corning Life Sciences Business Overview
13.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Introduction
13.2.4 Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.2.5 Corning Life Sciences Recent Development
13.3 GEA Group
13.3.1 GEA Group Company Details
13.3.2 GEA Group Business Overview
13.3.3 GEA Group Pharmaceutical Continuous Manufacturing Introduction
13.3.4 GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.3.5 GEA Group Recent Development
13.4 S K Biotek
13.4.1 S K Biotek Company Details
13.4.2 S K Biotek Business Overview
13.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Introduction
13.4.4 S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.4.5 S K Biotek Recent Development
13.5 Scott Equipment Company
13.5.1 Scott Equipment Company Company Details
13.5.2 Scott Equipment Company Business Overview
13.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Introduction
13.5.4 Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.5.5 Scott Equipment Company Recent Development
13.6 Korsch
13.6.1 Korsch Company Details
13.6.2 Korsch Business Overview
13.6.3 Korsch Pharmaceutical Continuous Manufacturing Introduction
13.6.4 Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.6.5 Korsch Recent Development
13.7 Continuus Pharmaceuticals
13.7.1 Continuus Pharmaceuticals Company Details
13.7.2 Continuus Pharmaceuticals Business Overview
13.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Introduction
13.7.4 Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.7.5 Continuus Pharmaceuticals Recent Development
13.8 Chemtrix
13.8.1 Chemtrix Company Details
13.8.2 Chemtrix Business Overview
13.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Introduction
13.8.4 Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.8.5 Chemtrix Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrix
【免責事項】
https://www.globalresearch.jp/disclaimer